Kraig Biocraft Laboratories Inc (KBLB)

[WebSlinger]

Here are two more changes to the recent S-1A (#10):

- Combatting silkworm diseases is no longer an integral part of the company, which seems to indicate that they have abandoned their line of disease resistant silkworms.

The following text has been removed:

"Combatting silkworm diseases and finding new solutions is an integral part of our operations, including research and development on immune-enhanced silkworms."

- A new risk has been identified by KBLB in the most recent S-1A (#10). It indicates that their wimpy worms had succumbed to disease (on top of being allergic to the cold). This has never been mentioned by the company previously.

"Our ability to produce our products in a cost-effective manner will depend on our ability to improve the robustness and tolerance of our silkworm to conditions in the production environment.

Working with our contract manufacturer in Vietnam we have identified robustness and acclimation of our silkworm strains to the local climate as the most significant challenges to production. We are working to overcome these challenges by acclimating our silkworms to the local environment and accelerating the introduction of our multi-strain hybrids. If we are unable to improve the robustness, including disease and environmental tolerance, of our silkworms, we may not be able to generate product revenue and may not become profitable."